107 related articles for article (PubMed ID: 17590957)
1. Mechanistic investigation into complementary (antisense) peptide mini-receptor inhibitors of cytokine interleukin-1.
Hea JR; Bino S; Roberts GW; Raynes JG; Miller AD
Chembiochem; 2002 Jan; 3(1):76-85. PubMed ID: 17590957
[TBL] [Abstract][Full Text] [Related]
2. Sense-antisense (complementary) peptide interactions and the proteomic code; potential opportunities in biology and pharmaceutical science.
Miller AD
Expert Opin Biol Ther; 2015 Feb; 15(2):245-67. PubMed ID: 25584818
[TBL] [Abstract][Full Text] [Related]
3. A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1beta trigger loop which binds to IL-1 and inhibits in vitro responses.
Heal JR; Bino S; Ray KP; Christie G; Miller AD; Raynes JG
Mol Immunol; 1999 Dec; 36(17):1141-8. PubMed ID: 10698316
[TBL] [Abstract][Full Text] [Related]
4. Genetic coding algorithm for sense and antisense peptide interactions.
Štambuk N; Konjevoda P; Turčić P; Kövér K; Kujundžić RN; Manojlović Z; Gabričević M
Biosystems; 2018 Feb; 164():199-216. PubMed ID: 29107641
[TBL] [Abstract][Full Text] [Related]
5. De-novo design of complementary (antisense) peptide mini-receptor inhibitor of interleukin 18 (IL-18).
Bhakoo A; Raynes JG; Heal JR; Keller M; Miller AD
Mol Immunol; 2004 Nov; 41(12):1217-24. PubMed ID: 15482857
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of beta-amyloid aggregation and neurotoxicity by complementary (antisense) peptides.
Heal JR; Roberts GW; Christie G; Miller AD
Chembiochem; 2002 Jan; 3(1):86-92. PubMed ID: 17590958
[TBL] [Abstract][Full Text] [Related]
7. Specific interactions between sense and complementary peptides: the basis for the proteomic code.
Heal JR; Roberts GW; Raynes JG; Bhakoo A; Miller AD
Chembiochem; 2002 Mar; 3(2-3):136-51. PubMed ID: 11921391
[TBL] [Abstract][Full Text] [Related]
8. Assessing the preferred solution conformation of an interacting sense-antisense (complementary) peptide pair.
Pullen JR; Dalmaris J; Serapian SA; Miller AD
Bioorg Med Chem Lett; 2013 Jan; 23(2):496-502. PubMed ID: 23245517
[TBL] [Abstract][Full Text] [Related]
9. The statistical significance of selected sense-antisense peptide interactions.
Illingworth CJ; Chintipalli SV; Serapian SA; Miller AD; Veverka V; Carr MD; Reynolds CA
J Comput Chem; 2012 Jun; 33(16):1440-7. PubMed ID: 22488506
[TBL] [Abstract][Full Text] [Related]
10. On the peptide-antipeptide interactions in interleukin-1 receptor system.
Kluczyk A; Cebrat M; Zbozień-Pacamaj R; Lisowski M; Stefanowicz P; Wieczorek Z; Siemion IZ
Acta Biochim Pol; 2004; 51(1):57-66. PubMed ID: 15094825
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides.
Fassina G; Cassani G; Gnocchi P; Fornasiero MC; Isetta AM
Arch Biochem Biophys; 1995 Apr; 318(1):37-45. PubMed ID: 7726570
[TBL] [Abstract][Full Text] [Related]
12. Making sense from antisense: a review of experimental data and developing ideas on sense--antisense peptide recognition.
Tropsha A; Kizer JS; Chaiken IM
J Mol Recognit; 1992 Jun; 5(2):43-54. PubMed ID: 1472380
[TBL] [Abstract][Full Text] [Related]
13. Antisense homology boxes in C5a receptor and C5a anaphylatoxin: a new method for identification of potentially active peptides.
Baranyi L; Campbell W; Okada H
J Immunol; 1996 Nov; 157(10):4591-601. PubMed ID: 8906838
[TBL] [Abstract][Full Text] [Related]
14. The possible role of sense and antisense peptide interactions in the generation and maintenance of the tertiary structure of a protein.
Okada H
Anticancer Res; 1998; 18(5D):3927-30. PubMed ID: 9854505
[TBL] [Abstract][Full Text] [Related]
15. Interactions and uses of antisense peptides in affinity technology.
Chaiken I
J Chromatogr; 1992 Apr; 597(1-2):29-36. PubMed ID: 1517330
[TBL] [Abstract][Full Text] [Related]
16. Antisense peptide recognition of sense peptides: sequence simplification and evaluation of forces underlying the interaction.
Shai Y; Brunck TK; Chaiken IM
Biochemistry; 1989 Oct; 28(22):8804-11. PubMed ID: 2605221
[TBL] [Abstract][Full Text] [Related]
17. Molecular Recognition Theory of the complementary (antisense) peptide interactions.
Stambuk N; Konjevoda P; Boban-Blagaić A; Pokrić B
Theory Biosci; 2005 Apr; 123(4):265-75. PubMed ID: 18202868
[TBL] [Abstract][Full Text] [Related]
18. Interaction of α-melanocortin and its pentapeptide antisense LVKAT: effects on hepatoprotection in male CBA mice.
Houra K; Turčić P; Gabričević M; Weitner T; Konjevoda P; Stambuk N
Molecules; 2011 Aug; 16(9):7331-43. PubMed ID: 21873934
[TBL] [Abstract][Full Text] [Related]
19. Study on the degeneracy of antisense peptides using affinity chromatography.
Zhao R; Yu X; Liu H; Zhai L; Xiong S; Su T; Liu G
J Chromatogr A; 2001 Apr; 913(1-2):421-8. PubMed ID: 11355840
[TBL] [Abstract][Full Text] [Related]
20. A model for hydropathy-based peptide interactions.
Markus G; Tritsch GL; Parthasarathy R
Arch Biochem Biophys; 1989 Aug; 272(2):433-9. PubMed ID: 2546500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
